Skip to content Skip to footer

Investigating the Future of Healthcare with Benjamin von Deschwanden, CPO and Co-Founder of Acodis AG.

Benjamin von Deschwanden, Co-Founder and CPO of Swiss software company Acodis AG, believes that Generative AI (Artificial Intelligence) and LLMs (Language Language Models) could have a significant impact on the healthcare industry by streamlining access to enormous volumes of information. Given the increasing size of data sets in healthcare, the rapid response capabilities of Generative AI could prove transformative, eliminating the laborious process of manually searching through source material.

Deschwanden highlights the critical need for accuracy within this context, emphasizing the costly consequences of erroneous data, particularly in healthcare where lives are at risk. He asserts that a central challenge of Generative AI technology is ensuring the information it generates is both correct and comprehensive.

At Acodis, the team is actively developing practical applications of Generative AI. These endeavors are specifically built into their Intelligent Document Processing (IDP) Platform, which is utilized by clients in the Life Science and Pharma sectors. Deschwanden explains that this tool, designed to manage and automate data extraction and document processing, will increase operational efficiency and speed up the time to market for these clients, while concurrently managing all associated risks.

In summary, Deschwanden sees significant potential in harnessing Generative AI technology for the healthcare industry – a sector that is infamous for vast, complex data volumes. His company, Acodis, is taking steps to unlock this potential, by integrating AI functionality into its proprietary platform for a range of clients. Deschwanden emphasizes, though, that great care must be taken to ensure all AI–generated information is accurate and complete, given the gravity of consequence in the healthcare field.

Leave a comment

0.0/5